Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial

Guillaume Marquis-Gravel, Matthew T. Roe, Holly R. Robertson, Robert A. Harrington, Michael J. Pencina, Lisa G. Berdan, Bradley G. Hammill, Madelaine Faulkner, Daniel Munõz, Gregg C. Fonarow, Brahmajee K. Nallamothu, Dan J. Fintel, Daniel E. Ford, Li Zhou, Sarah E. Daugherty, Elizabeth Nauman, Jennifer Kraschnewski, Faraz S. Ahmad, Catherine P. Benziger, Kevin HaynesJ. Greg Merritt, Thomas Metkus, Sunil Kripalani, Kamal Gupta, Raj C. Shah, James C. McClay, Richard N. Re, Carol Geary, Brent C. Lampert, Steven M. Bradley, Sandeep K. Jain, Hani Seifein, Jeff Whittle, Véronique L. Roger, Mark B. Effron, Giselle Alvarado, Ythan H. Goldberg, Jeffrey L. Vanwormer, Saket Girotra, Peter Farrehi, Kathleen M. McTigue, Russell Rothman, Adrian F. Hernandez, W. Schuyler Jones

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences